Skip to main content
Erschienen in: Wiener klinische Wochenschrift 3-4/2021

20.05.2020 | original article

Combination value of biomarkers in discriminating adult onset Still’s disease and sepsis

verfasst von: Mengying Zhang, Mengxiao Xie, Yaman Wang, Jie Li, Jun Zhou

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 3-4/2021

Einloggen, um Zugang zu erhalten

Summary

Background

Lymphocyte and plateletcrit (PCT) as proportions of routine complete blood count tests, have been studied as simple biomarkers for inflammatory diseases. The aim of our study was to investigate whether blood routine parameters, especially platelet parameters could be a useful tool to distinguish Adult onset Still’s disease (AOSD) from sepsis.

Methods

We retrospectively reviewed 58 patients with AOSD and 55 sepsis patients diagnosed at the First Affiliated Hospital of Nanjing Medical University between January, 2015 to December 2018. Laboratory data including ferritin, blood routine parameters and C‑reactive protein (CRP) level were collected, and the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte (PLR) were calculated.

Results

The results showed that AOSD patients showed higher ferritin, lymphocyte and PCT (all P < 0.01) and these factors are independent risk factors for predicting AOSD. In receiver operating characteristic (ROC) curve analysis of LY, PCT and ferritin for distinguish of AOSD, the area under the curve (AUC) was 0.676 (0.576–0.777); 0.706 (95% CI = 0.596–0.816); 0.715 (0.617–0.814). Meanwhile, the AUC of the combination of lymphocyte, PCT and ferritin was 0.836 (0.737–0.909) with sensitivity 67.3, specificity 92.3, and the difference was significant.

Conclusions

Thus we suggest that lymphocyte, PCT may be a useful tool to make a distinction between AOSD and sepsis, as supplementary biomarkers to ferritin.
Literatur
1.
Zurück zum Zitat Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992;19:424–30.PubMed Yamaguchi M, Ohta A, Tsunematsu T, et al. Preliminary criteria for classification of adult Still’s disease. J Rheumatol. 1992;19:424–30.PubMed
2.
Zurück zum Zitat Fautrel B, Zing E, Golmard JL, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore). 2002;81:194–200.CrossRef Fautrel B, Zing E, Golmard JL, et al. Proposal for a new set of classification criteria for adult-onset still disease. Medicine (Baltimore). 2002;81:194–200.CrossRef
3.
Zurück zum Zitat Cush JJ. Adult-onset Still’s disease. Bull Rheum Dis. 2000;49:1–4.PubMed Cush JJ. Adult-onset Still’s disease. Bull Rheum Dis. 2000;49:1–4.PubMed
4.
Zurück zum Zitat Mitrovic S, Fautrel B. New markers for adult-onset Still’s disease. Joint Bone Spine. 2018;85:285–93.CrossRef Mitrovic S, Fautrel B. New markers for adult-onset Still’s disease. Joint Bone Spine. 2018;85:285–93.CrossRef
5.
Zurück zum Zitat Gerfaud-Valentin M, Maucort-Boulch D, Hot A, et al. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore). 2014;93:91–9.CrossRef Gerfaud-Valentin M, Maucort-Boulch D, Hot A, et al. Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients. Medicine (Baltimore). 2014;93:91–9.CrossRef
6.
Zurück zum Zitat Priori R, Colafrancesco S, Alessandri C, et al. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still’s disease and sepsis. J Rheumatol. 2014;41:1118–23.CrossRef Priori R, Colafrancesco S, Alessandri C, et al. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still’s disease and sepsis. J Rheumatol. 2014;41:1118–23.CrossRef
7.
Zurück zum Zitat Klein Klouwenberg PM, Ong DS, Bonten MJ, Cremer OL. Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria. Intensive Care Med. 2012;38:811–9.CrossRef Klein Klouwenberg PM, Ong DS, Bonten MJ, Cremer OL. Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria. Intensive Care Med. 2012;38:811–9.CrossRef
8.
Zurück zum Zitat Lee SW, Park YB, Song JS, Lee SK. The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still’s disease. J Rheumatol. 2009;36:156–62.CrossRef Lee SW, Park YB, Song JS, Lee SK. The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still’s disease. J Rheumatol. 2009;36:156–62.CrossRef
9.
Zurück zum Zitat Hanaganahalli SB, Sreeram S, Bompada M, Kuppannagari SK, Suresh PK, Philipose CS. Is MPV a predictive marker for neonatal sepsis? A pilot study. J Pediatr Hematol Oncol. 2018;40:548–52.CrossRef Hanaganahalli SB, Sreeram S, Bompada M, Kuppannagari SK, Suresh PK, Philipose CS. Is MPV a predictive marker for neonatal sepsis? A pilot study. J Pediatr Hematol Oncol. 2018;40:548–52.CrossRef
10.
Zurück zum Zitat Dursun A, Ozsoylu S, Akyildiz BN. Neutrophil-to-lymphocyte ratio and mean platelet volume can be useful markers to predict sepsis in children. Pak J Med Sci. 2018;34:918–22.CrossRef Dursun A, Ozsoylu S, Akyildiz BN. Neutrophil-to-lymphocyte ratio and mean platelet volume can be useful markers to predict sepsis in children. Pak J Med Sci. 2018;34:918–22.CrossRef
11.
Zurück zum Zitat Shaaban HA, Safwat N. Mean platelet volume in preterm: a predictor of early onset neonatal sepsis. J Matern Fetal Neonatal Med. 2020;33(2):206–11.CrossRef Shaaban HA, Safwat N. Mean platelet volume in preterm: a predictor of early onset neonatal sepsis. J Matern Fetal Neonatal Med. 2020;33(2):206–11.CrossRef
12.
Zurück zum Zitat ACCP/SCCM. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–74.CrossRef ACCP/SCCM. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992;20:864–74.CrossRef
13.
Zurück zum Zitat Kim HA, Sung JM, Suh CH. Therapeutic responses and prognosis in adult-onset Still’s disease. Rheumatol Int. 2012;32:1291–8.CrossRef Kim HA, Sung JM, Suh CH. Therapeutic responses and prognosis in adult-onset Still’s disease. Rheumatol Int. 2012;32:1291–8.CrossRef
14.
Zurück zum Zitat Ohta A, Yamaguchi M, Tsunematsu T, et al. Adult Still’s disease: a multicenter survey of Japanese patients. J Rheumatol. 1990;17:1058–63.PubMed Ohta A, Yamaguchi M, Tsunematsu T, et al. Adult Still’s disease: a multicenter survey of Japanese patients. J Rheumatol. 1990;17:1058–63.PubMed
15.
Zurück zum Zitat Zeng T, Zou YQ, Wu MF, Yang CD. Clinical features and prognosis of adult-onset still’s disease: 61 cases from China. J Rheumatol. 2009;36:1026–31.CrossRef Zeng T, Zou YQ, Wu MF, Yang CD. Clinical features and prognosis of adult-onset still’s disease: 61 cases from China. J Rheumatol. 2009;36:1026–31.CrossRef
16.
Zurück zum Zitat Priori R, Colafrancesco S, Gattamelata A, Di Franco M, Di Tondo U, Valesini G. Adult-onset Still disease: a rare disorder with a potentially fatal outcome. Auto Immun Highlights. 2010;1:53–9.CrossRef Priori R, Colafrancesco S, Gattamelata A, Di Franco M, Di Tondo U, Valesini G. Adult-onset Still disease: a rare disorder with a potentially fatal outcome. Auto Immun Highlights. 2010;1:53–9.CrossRef
17.
Zurück zum Zitat Zhao D, Qiu G, Luo Z, Zhang Y. Platelet parameters and (1, 3)-beta-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants. PLoS One. 2015;10:e123907.CrossRef Zhao D, Qiu G, Luo Z, Zhang Y. Platelet parameters and (1, 3)-beta-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants. PLoS One. 2015;10:e123907.CrossRef
18.
Zurück zum Zitat Bilgin E, Hayran M, Erden A, et al. Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study. Clin Rheumatol. 2019;38(6):1699–706.CrossRef Bilgin E, Hayran M, Erden A, et al. Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study. Clin Rheumatol. 2019;38(6):1699–706.CrossRef
19.
Zurück zum Zitat Seo JY, Suh CH, Jung JY, Kim AR, Yang JW, Kim HA. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still’s disease: a STROBE-compliant retrospective observational analysis. Medicine (Baltimore). 2017;96:e7546.CrossRef Seo JY, Suh CH, Jung JY, Kim AR, Yang JW, Kim HA. The neutrophil-to-lymphocyte ratio could be a good diagnostic marker and predictor of relapse in patients with adult-onset Still’s disease: a STROBE-compliant retrospective observational analysis. Medicine (Baltimore). 2017;96:e7546.CrossRef
20.
Zurück zum Zitat Lee YH, Song GG. Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behcet’s disease and their correlation with disease activity: a meta-analysis. Int J Rheum Dis. 2018;21:2180–7.CrossRef Lee YH, Song GG. Neutrophil-to-lymphocyte ratio, mean platelet volume and platelet-to-lymphocyte ratio in Behcet’s disease and their correlation with disease activity: a meta-analysis. Int J Rheum Dis. 2018;21:2180–7.CrossRef
Metadaten
Titel
Combination value of biomarkers in discriminating adult onset Still’s disease and sepsis
verfasst von
Mengying Zhang
Mengxiao Xie
Yaman Wang
Jie Li
Jun Zhou
Publikationsdatum
20.05.2020
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 3-4/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-020-01668-z

Weitere Artikel der Ausgabe 3-4/2021

Wiener klinische Wochenschrift 3-4/2021 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in wien

Veranstaltungstipps:

MUW researcher of the month

MUW researcher of the month